Botulinum toxin for primary disorders of mood and affect using neurotransmitter
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A botulinum toxin and neurotransmitter technology, which is applied in neuromuscular system diseases, nervous system diseases, muscular system diseases, etc., can solve problems such as unexplainable and uncertain statistical significance
Inactive Publication Date: 2018-12-21
REVANCE THERAPEUTICS INC
View PDF8 Cites 1 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
However, the statistical significance of these results was uncertain, with conflicting treatment groups showing unexplained inverted dose-response curves (Silberstein et al. (2000) Botulinum toxin type A as amigraine preventive treatment. Headache 40(6 ):445-50)
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0224] A 78-year-old man with documented sleep disturbance and anxiety was initially diagnosed with blepharospasm. Subjects who administered botulinum toxin by injection recorded improved sleep and reduced anxiety.
Embodiment 2
[0226] A 44-year-old bus driver was diagnosed with hemifacial spasm and reported symptoms of anxiety. Botulinum toxin is administered by injection. Subjects recorded a better ability to cope with work-related stress and to cope with difficult situations with less stress.
Embodiment 3
[0228] Botulinum toxin administered by injection in the treatment of a 72-year-old consultant with a diagnosis of hemifacial spasm who reported sleep disturbance and anxiety. Subjects reported improved sleep and reduced anxiety and agitation.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Property
Measurement
Unit
molecular weight
aaaaa
aaaaa
Login to view more
Abstract
The invention provides methods for treating primary disorders of mood and affect, including depressive disorders, anxiety, and sleep disorders and CNS disorders comprising the administration of a neurotoxin.
Description
[0001] This application claims the benefit of U.S. Patent Application Serial No. 14 / 464,740, filed August 21, 2014, which claims priority to U.S. Patent Application Serial No. 11 / 447,984, filed June 7, 2006, which claims four priority Rights: U.S. Provisional Application No. 60 / 690,162, filed June 14, 2005; U.S. Provisional Application No. 60 / 693,771, filed June 27, 2005; U.S. Provisional Application No. 60 / 721,060, filed September 28, 2005; US Provisional Application No. 60 / 738,981, filed November 23, 2005, is hereby incorporated by reference in its entirety. field of invention [0002] The present invention relates to the use of neurotoxins in the treatment of primary mood and affective disorders, including depression, anxiety and sleep disorders, as well as other CNS disorders. The present invention relates to neurotransmitter imaging of parts of the brain and central nervous system for the selection of patients for botulinum administration and for the selection of suitable...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more